Iktos

Iktos is a Paris-based company specializing in AI-driven drug discovery, focusing on integrating AI-driven molecular generation, automated synthesis, and biological testing.

Iktos Secures EIC Grant to Enhance AI Drug Discovery Platform

February 21, 2025

Iktos has received a €2.5 million grant from the European Innovation Council to advance its AI and robotics platform for drug discovery.
Free newsletter

Daily AI Brief

Daily report covering major AI developments and industry news, with both top stories and complete market updates